Deltex Medical Group (DEMG) Competitors

GBX 0.12
+0.01 (+4.17%)
(As of 12:05 PM ET)

DEMG vs. SUN, MHC, RUA, POLX, HELD, N4P, IDHC, PYC, TRLS, and NFX

Should you be buying Deltex Medical Group stock or one of its competitors? The main competitors of Deltex Medical Group include Surgical Innovations Group (SUN), MyHealthChecked (MHC), RUA Life Sciences (RUA), Polarean Imaging (POLX), Hellenic Dynamics (HELD), N4 Pharma (N4P), Integrated Diagnostics (IDHC), Physiomics (PYC), Trellus Health (TRLS), and Nuformix (NFX). These companies are all part of the "medical" sector.

Deltex Medical Group vs.

Deltex Medical Group (LON:DEMG) and Surgical Innovations Group (LON:SUN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Deltex Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Surgical Innovations Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Surgical Innovations Group has higher revenue and earnings than Deltex Medical Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Deltex Medical Group£1.78M1.33-£1.28MN/AN/A
Surgical Innovations Group£12.01M0.37N/AN/AN/A

Deltex Medical Group has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Surgical Innovations Group has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500.

Surgical Innovations Group received 62 more outperform votes than Deltex Medical Group when rated by MarketBeat users. Likewise, 68.36% of users gave Surgical Innovations Group an outperform vote while only 64.84% of users gave Deltex Medical Group an outperform vote.

CompanyUnderperformOutperform
Deltex Medical GroupOutperform Votes
59
64.84%
Underperform Votes
32
35.16%
Surgical Innovations GroupOutperform Votes
121
68.36%
Underperform Votes
56
31.64%

17.5% of Deltex Medical Group shares are held by institutional investors. Comparatively, 40.2% of Surgical Innovations Group shares are held by institutional investors. 67.5% of Deltex Medical Group shares are held by company insiders. Comparatively, 48.2% of Surgical Innovations Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Surgical Innovations Group has a net margin of -4.24% compared to Deltex Medical Group's net margin of -72.18%. Surgical Innovations Group's return on equity of -4.75% beat Deltex Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Deltex Medical Group-72.18% -47.74% -7.18%
Surgical Innovations Group -4.24%-4.75%-2.49%

In the previous week, Surgical Innovations Group had 2 more articles in the media than Deltex Medical Group. MarketBeat recorded 2 mentions for Surgical Innovations Group and 0 mentions for Deltex Medical Group. Surgical Innovations Group's average media sentiment score of 0.28 beat Deltex Medical Group's score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the news media.

Company Overall Sentiment
Deltex Medical Group Neutral
Surgical Innovations Group Neutral

Summary

Surgical Innovations Group beats Deltex Medical Group on 9 of the 13 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DEMG vs. The Competition

MetricDeltex Medical GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£2.38M£2.07B£5.00B£1.43B
Dividend Yield2.19%2.48%2.84%11.93%
P/E Ratio-5.75236.87190.211,667.75
Price / Sales1.33251.662,336.71324,658.46
Price / Cash9.0015.8133.5432.84
Price / BookN/A4.264.922.67
Net Income-£1.28M£58.06M£105.35M£176.41M
7 Day Performance-6.02%0.75%0.34%1.20%
1 Month PerformanceN/A-2.53%-3.63%6.74%
1 Year Performance-91.94%41.01%3.34%8.39%

Deltex Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SUN
Surgical Innovations Group
0 of 5 stars
GBX 0.48
-5.0%
N/A-75.7%£4.43M£12.01M-21.11100Gap Down
MHC
MyHealthChecked
0 of 5 stars
GBX 10.24
+2.4%
N/A+775.0%£5.33M£14.95M316.6721Gap Down
RUA
RUA Life Sciences
0 of 5 stars
GBX 11.48
-0.2%
N/A-73.4%£7.12M£1.87M-143.4448
POLX
Polarean Imaging
0 of 5 stars
GBX 3.74
+0.9%
N/A-85.4%£8.08M£1.03M-74.7028Gap Down
HELD
Hellenic Dynamics
0 of 5 stars
GBX 1.89
-12.1%
N/AN/A£2.38MN/A0.00N/AGap Up
High Trading Volume
N4P
N4 Pharma
0 of 5 stars
GBX 0.75
-6.3%
N/A-62.5%£2.02M£23,524.00-75.005
IDHC
Integrated Diagnostics
0 of 5 stars
GBX 0.32
+1.9%
N/A-32.1%£1.94M£4.12B16.156,692High Trading Volume
PYC
Physiomics
0 of 5 stars
GBX 1.39
+3.0%
N/A-56.7%£1.88M£900,707.00-13.8310Gap Up
TRLS
Trellus Health
0 of 5 stars
GBX 1.77
+1.1%
N/A-78.6%£2.86M£35,000.00-59.0031Gap Down
NFX
Nuformix
0 of 5 stars
GBX 0.19
flat
N/A-27.5%£1.52M£50,000.00-1.633Gap Down

Related Companies and Tools

This page (LON:DEMG) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners